Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Systemic Sclerosis' Relatives Reflex (RelativReflex)

19 de novembro de 2021 atualizado por: Assistance Publique - Hôpitaux de Paris

"Family Caregiver Reflex": Family Support for Patients Followed for Systemic Sclerosis - Pilot Study Evaluating the Experience and Role of Family Caregivers in Order to Identify and Include Them in Therapeutic Educational Programs

Systemic sclerosis (SSc) is a rare, serious disease that is part of chronic inflammatory rheumatism.

It requires multidisciplinary care and a specific therapeutic patient education program.

SSc actually affects every member of the family, the patient as well as those close to him. It deeply affects each member of the family (increased fatigue, stress, social isolation, exhaustion, financial difficulties …) which gives rise to threats of vulnerability and modulates the balance of family relations.

However, there are very few studies on family SSc caregivers. We have raised the question about the experience and needs of caregivers in order to better support them.

The main purpose of this pilot study is to better understand the particularities of relatives (caregivers) of patients suffering from systemic sclerosis and will allow us to refine our knowledge about the assistance they provide for SSc patients and its impact on family caregivers :

  • lived experience of the relatives (caregivers);
  • physical, mental and socio-professional health of the relatives (caregiver);
  • relationship between the relative (caregiver) and the patient.

The research will be carried out at Cochin Hospital, in collaboration with the French Scleroderma Association (ASF).

It will be offered to relatives of SSc patients identified by health team in the rheumatology or internal medicine department, as well as during consultations and patient education activities.

An information note and an informed consent will be given to each patient and his caregiver ; Self-questionnaires will then be offered to relatives.

They can fill them out while they are in the hospital, or at home and return the completed questionnaire.

Caregivers will be questioned about their quality of life, health, relationship with the patient and support situation.

They will also be asked for personal socio-demographic information concerning the patient.

The "caregiver reflex" project is part of the 2020-2022 mobilization and support strategy for caregivers "acting for the health of family caregivers", in which the establishment of a "caregiver reflex" among professionals health is put forward.

Visão geral do estudo

Descrição detalhada

Exploratory study with family caregivers of patients suffering from Systemic Sclerosis (SSc).

This research work will allow to better understand the experiences and needs of these very particular caregivers, in order to offer them specific educational support and workshops.

It should also allow healthcare teams to develop a "family caregiver reflex", especially in the context of SSc disease to identify and include PAs in PTE programs.

Primary objectives:

Identify caregivers in the SCS patient's family circle: in order to analyze their profile and assess their needs, expectations, projects and difficulties:

  • Identify who are the caregivers of SSc people: epidemiological data, profiles of SSc patients followed in rheumatology and Internal medicine departments of Cochin hospital (sex, age, professional activity, possible presence of young people in the entourage, etc.);
  • assess the assistance provided by the caregivers: type and specificity;
  • Specify the experience and feelings of the caregivers in relation to this aid (positive or negative impact)
  • Identify fragile-vulnerable caregivers .

Secondary objectives:

Develop, from this data, educational tools to share with the other members of the FSMR FAI2R and specifically dedicated to the caregivers of SSc patients:

  • "Caregiver reflex" tool intended for professionals to better identify and identify caregivers of SSc patients;
  • Specific interview guide for the educational diagnosis of caregivers;
  • Examples of educational workshops for caregivers meeting identified needs (workshop experienced by the illness of the other, stress management, fatigue, dietary advice, lifestyle, to assist persons in administrative and social procedures...)

Tipo de estudo

Observacional

Inscrição (Antecipado)

50

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Marie BENHAMMANI-GODARD
  • Número de telefone: 00 33 1 58 41 11 90
  • E-mail: marie.godard@aphp.fr

Estude backup de contato

Locais de estudo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

Participants:

relatives of patients suffering from Systemic Scleroderma

Two possible inclusion methods:

  1. At the hospital, via health professionals (doctor, nurse, social worker, etc.) who identify the loved one accompanying the patient during a consultation or hospitalization;
  2. Via the French Scleroderma Association - ASF (call for participation)

They will be presented with the study by the recruiting psychologist or education nurse and given an information note and consent to participate. Patients will also be presented with an information letter and consent to participate .

Descrição

Inclusion Criteria:

  • Relatives caregivers of patients suffering from Systemic Scleroderma (family, friends, neighbours);
  • Be at least 18 years old;
  • Not being the patient's professional caregiver;
  • Have signed the informed consent to participate.

Exclusion Criteria:

  • Inability to answer questionnaires (language, cognitive disorders, etc.).
  • under curatorship or tutorship
  • with State medical care (AME)

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Coortes e Intervenções

Grupo / Coorte
Intervenção / Tratamento
Caregivers (CG)
Caregivers of patients with systemic Scleroderma

Sociodemographic and medical information for the patient and the CG. SF36 questionnaire for the quality of life (physical, mental) of family CGs This assessment will be supplemented by specific questions relating to: physical health, emotional state, personal and leisure activities of the caregiver.

The CG's knowledge and representations of the disease : questions adapted from the Brief-IPQ disease representation questionnaire.

Questions will also focus on the caregiver's reactions to the patient's illness.

We have constructed a questionnaire to assess the main areas of aid in the context of SSc: emotional, domestic help, administrative, medical, for trave (16 items and an open question).

The CG Reaction Assessment-CRA questionnaire to assess the positive and negative dimensions of helping (24 items). It assesses five dimensions: self-esteem, financial impact, impact on health, impact on time and lack of family support.

The reason for the assistance provided.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Questionnaire
Prazo: Inclusion visit 1 day
Sociodemographic and medical information concerning the patient assisted Patients' sociodemographic and medical information will be collected: age, gender, family composition, family relationship with the family caregiver, length of the illness.
Inclusion visit 1 day

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Questionnaire
Prazo: Inclusion visit 1 day
Socio-demographic information about the caregiver Sociodemographic information will be collected on the informal caregiver: age, sex, professional situation, seniority of the help.
Inclusion visit 1 day
Questionnaire SF36
Prazo: Inclusion visit 1 day

Physical and mental health The SF36 questionnaire (Leplège et al., 1998) will be used to assess the quality of life of family caregivers.

This widely used questionnaire is divided on 6 items assessing the physical and mental quality of life.

This assessment will be supplemented by specific questions relating to:

  • Physical health: presence of chronic pathologies, medical monitoring, taking treatment, health behaviors (diet, tobacco, alcohol);
  • The emotional state;
  • The personal and leisure activities of the caregiver.
Inclusion visit 1 day
Questionnaire
Prazo: Inclusion visit 1 day

The relationship with the patient The caregiver's knowledge and representations of the disease will be assessed using questions adapted from the Brief-IPQ disease representation questionnaire (Broadbent et al., 2006).

Questions will also focus on the caregiver's reactions to the patient's illness.

Inclusion visit 1 day
Questionnaire
Prazo: Inclusion visit 1 day
Aid activities To date, there is no questionnaire to assess the aid activity in the context of chronic inflammatory rheumatism. The existing questionnaires on the subject being too often linked to situations of significant dependence, as in the context of neurodegenerative diseases, we have constructed a questionnaire to assess the main areas of aid in the context of SSc: emotional, domestic help , administrative, medical, for travel. It is composed of 16 items and an open question.
Inclusion visit 1 day
Questionnaire
Prazo: Inclusion visit 1 day

Positive and negative dimensions of aid The Caregiver Reaction Assessment-CRA questionnaire (Given et al., 1992) will be used to assess the positive and negative dimensions of helping. This questionnaire has 24 items. It assesses five dimensions: self-esteem, financial impact, impact on health, impact on time and lack of family support.

Finally, two questions are asked to assess the reason for the assistance provided.

Inclusion visit 1 day

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Janine-Sophie Giraudet-Le Quintrec, MD, Cochin Hospital - APHP

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

23 de junho de 2021

Conclusão Primária (Antecipado)

23 de junho de 2022

Conclusão do estudo (Antecipado)

23 de junho de 2022

Datas de inscrição no estudo

Enviado pela primeira vez

27 de maio de 2021

Enviado pela primeira vez que atendeu aos critérios de CQ

7 de junho de 2021

Primeira postagem (Real)

8 de junho de 2021

Atualizações de registro de estudo

Última Atualização Postada (Real)

2 de dezembro de 2021

Última atualização enviada que atendeu aos critérios de controle de qualidade

19 de novembro de 2021

Última verificação

1 de novembro de 2021

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

3
Se inscrever